AI in Medicine News ・ 🩻 Diagnosis and imaging

FDA Grants Breakthrough Device Designation to Cleo Skin AI Pathology Tool

Clinical Lab Products · 11/06 19:09 UTC

The FDA granted Breakthrough Device Designation to Primaa's Cleo Skin AI pathology tool. The tool now has both CE-IVDR and FDA status.

Read the original (Clinical Lab Products)

See it in the digest → ・ See this issue →